Table 1.
Characteristics of the Study Population (N = 29 956)
| Variable | |
|---|---|
| Mean age (SD) | 41.8 (13.2) |
| Age categories, years %(N) | |
| ≤25 | 13.6 (4068) |
| 26–35 | 16.8 (5040) |
| 36–45 | 24.0 (7190) |
| 46–55 | 27.3 (8189) |
| >55 | 18.3 (5469) |
| Male gender %(N) | 51.7 (15 473) |
| Time since diagnoses, years %(N) | |
| ≤5 | 10.7 (3203) |
| 6–10 | 12.8 (3832) |
| 11–20 | 27.2 (8135) |
| >20 | 49.4 (14 786) |
| Primary nonadherence to any antipsychotic %(N) | 31.7 (9506) |
| Comorbid conditions %(N) | |
| Cardiovascular disease %(N) | 25.1 (7505) |
| Diabetes %(N) | 11.0 (3294) |
| Asthma/ COPD %(N) | 7.8 (2350) |
| Substance abuse %(N) | 21.2 (6358) |
| Previous suicide attempt %(N) | 10.7 (3215) |
| Other medication use %(N) | |
| Benzodiazepine and related drug use | 46.7 (14 002) |
| Antidepressant use | 35.5 (10 645) |
| Mood stabilizer use | 24.2 (7261) |